Abstract
Abstract Date Presented 04/21/2023 This study identified unique OT needs of older adults with acute myeloid leukemia (AML) receiving oral venetoclax and infusional hypomethalating agent (VEN + HMA) therapy. A battery of tests performed on 19 older adults in the early stages of chemotherapy suggest that grip strength and mobility decline and the need for more nuanced evaluation of cognition. We found careful evaluation was important to understand cognitive and physical impairments in the context of meaningful occupational challenges. Primary Author and Speaker: Farrell Leigh Wiggins Additional Authors and Speakers: Alexis Petteway Contributing Authors: Mackenzi Pergolotti, Todd Schwartz, Zachary Ripberger, Susan Coppola, Ashley Bryant, Ya-Ning Chan
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
